Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2017

Lowest Prices Guaranteed	Length	Publisher	Published Date	SKU
from $4,000	100 Pages	GlobalData	September, 2017	GBDT15469550

Lowest Prices Guaranteed
Price	from $4,000
Length	100 Pages
Publisher	GlobalData
Published Date	September, 2017
SKU	GBDT15469550

Single User License:	$4,000
Site License:	$8,000
Global Site License:	$12,000

Research assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2017 provides an overview of Ophthalmic Imaging Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Imaging Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Ophthalmic Imaging Equipment under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Ophthalmic Imaging Equipment and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Ophthalmic Imaging Equipment Overview 8

3 Products under Development 9

3.1 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 9

3.2 Ophthalmic Imaging Equipment - Pipeline Products by Segment 10

3.3 Ophthalmic Imaging Equipment - Pipeline Products by Territory 11

3.4 Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 12

3.5 Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 13

3.6 Ophthalmic Imaging Equipment - Ongoing Clinical Trials 14

4 Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies 15

4.1 Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development 15

4.2 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 17

5 Ophthalmic Imaging Equipment Companies and Product Overview 18

5.1 Aeon Imaging, LLC Company Overview 18

5.1.1 Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 ArcScan, Inc. Company Overview 19

5.2.1 ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Ben-Gurion University of the Negev Company Overview 22

5.3.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 22

5.4 Bioinformative Institute of India Company Overview 23

5.4.1 Bioinformative Institute of India Pipeline Products & Ongoing Clinical Trials Overview 23

5.5 Brien Holden Vision Institute Company Overview 24

5.5.1 Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 24

5.6 Columbia University Company Overview 25

5.6.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 25

5.7 CW Optics Inc Company Overview 26

5.7.1 CW Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.8 Dalhousie University Company Overview 27

5.8.1 Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 27

5.9 Eye Marker Systems Inc (Inactive) Company Overview 28

5.9.1 Eye Marker Systems Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

5.10 Eye Tech Care SA Company Overview 29

5.10.1 Eye Tech Care SA Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 Fovioptics, Inc. (Inactive) Company Overview 32

5.11.1 Fovioptics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32

5.12 Gemss Co.,Ltd. Company Overview 33

5.12.1 Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 33

5.13 George Washington University Company Overview 34

5.13.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 34

5.14 Massachusetts Eye and Ear Infirmary Company Overview 35

5.14.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 35

5.15 Next Dimension Ltd. Company Overview 37

5.15.1 Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37

5.16 OcuSciences, Inc. Company Overview 38

5.16.1 OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

5.17 Ocutronics, LLC Company Overview 39

5.17.1 Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 39

5.18 Ohio State University Company Overview 40

5.18.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 40

5.19 Optos Plc Company Overview 41

5.19.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 41

5.20 PCAsso Diagnostics LLC Company Overview 45

5.20.1 PCAsso Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 45

5.21 Praevium Research Inc. Company Overview 46

5.21.1 Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 46

5.22 Predictek, Inc. Company Overview 47

5.22.1 Predictek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

5.23 Rensselaer Polytechnic Institute Company Overview 48

5.23.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 48

5.24 RetiVue, LLC Company Overview 49

5.24.1 RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.25 Ti-TaMed (PTY) LTD. Company Overview 50

5.25.1 Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 50

5.26 Tufts University Company Overview 51

5.26.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 51

5.27 University College London Company Overview 52

5.27.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 52

5.28 University of Arizona Company Overview 53

5.28.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 53

5.29 University of California Los Angeles Company Overview 54

5.29.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 54

5.30 University of Colorado Company Overview 55

5.30.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 55

5.31 University of South Florida Company Overview 56

5.31.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 56

5.32 University of Valencia Company Overview 57

5.32.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 57

5.33 Vasoptic Medical, Inc. Company Overview 58

5.33.1 Vasoptic Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

5.34 Vision Instruments Pty. Ltd. Company Overview 59

5.34.1 Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 59

5.35 VisionQuest Biomedical, LLC Company Overview 60

5.35.1 VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 60

5.36 Visual Pathways, Inc. (Inactive) Company Overview 62

5.36.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

6 Ophthalmic Imaging Equipment- Recent Developments 64

6.1 Jul 27, 2017: Quantel: First-Half Revenues Up 4.8% 64

6.2 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 65

6.3 May 28, 2017: Silverblatt Eye Clinic Offers Enhanced Eye Care with Optomap Retinal Exams in Northwest Louisiana 65

6.4 May 23, 2017: KARL STORZ Wins Inter Partes Review Trial Invalidating Novadaq Patent 66

6.5 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 66

6.6 May 08, 2017: Open Innovation of ZEISS and the Advanced Retina Imaging Network advances Swept-Source OCT technology for better vision care 67

6.7 May 08, 2017: ZEISS Appoints New Fellow 68

6.8 May 04, 2017: DigiSight Technologies Presents the Paxos Solution for Ophthalmic Teleconsultations at ARVO 2017 69

6.9 May 03, 2017: NOVADAQ Announces First Quarter 2017 Financial Results 69

6.10 Apr 27, 2017: ContextVision presents Q1 report 70

6.11 Apr 20, 2017: Canon Eye Care Technology to be on Display at the American Telemedicine Association 2017 Conference 71

6.12 Apr 12, 2017: Christian Zahnd appointed as Honorary Chairman of the Board of Directors as he decided not to stand for re-election as member of the Board of Directors at the Annual General Meeting 2017 72

6.13 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 72

6.14 Mar 20, 2017: Massachusetts Eye And Ear/Harvard Medical School Have Developed A Cheap, Portable Camera 72

6.15 Feb 28, 2017: NOVADAQ Announces Fourth Quarter And Full Year 2016 Financial Results 73

6.16 Feb 23, 2017: ContextVision presents Q4 and full year 2016 report 75

6.17 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 75

6.18 Feb 09, 2017: Molecular Partners reports preliminary unaudited key financials for 2016: Advancements across all therapeutic areas - Ongoing strong cash position 76

6.19 Jan 10, 2017: NOVADAQ Announces Preliminary Unaudited Fourth Quarter 2016 Revenue And Issues 2017 Revenue Guidance 79

6.20 Dec 19, 2016: Lensar Strategic Restructure In Partnership With Pdl Biopharma 80

6.21 Dec 18, 2016: Optomap Scanning for Eye Health at Primary Eyecare and Optical of Meridian 80

6.22 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend 81

6.23 Nov 09, 2016: Daniel B. Polley, Ph.D., appointed Director of Lauer Tinnitus Research Center at Mass. Eye and Ear 82

6.24 Nov 08, 2016: Canon U.S.A. to Exhibit Eye Care Devices and Solutions at American Academy of Optometry's Annual Meeting 83

6.25 Nov 07, 2016: Molecular Partners Announces Management Change 84

6.26 Nov 02, 2016: NOVADAQ Reports Third Quarter 2016 Financial Results 84

6.27 Oct 27, 2016: Molecular Partners: Quarterly Management Statement For The Period Ending September 30, 2016 85

6.28 Oct 27, 2016: ContextVision Presents Q3 2016 Financial Report 87

6.29 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 88

6.30 Oct 12, 2016: Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago 89

6.31 Oct 11, 2016: DigiSight Technologies Showcases State-of-the-Art Paxos Scope Mobile Imaging Solution At AAO 2016 92

6.32 Sep 28, 2016: Hill-Rom Adding More Than 100 Jobs In Central New York 92

6.33 Sep 12, 2016: Canon U.S.A. to Display Eyecare Devices and Solutions at Vision Expo West 93

6.34 Sep 01, 2016: Molecular Partners reports unaudited half-year results for 2016: A period of continued progress for Molecular Partners 94

7 Appendix 97

7.1 Methodology 97

7.2 About GlobalData 100

7.3 Contact Us 100

7.4 Disclaimer 100

1.1 List of Tables

Table 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 9

Table 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment 10

Table 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory 11

Table 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 12

Table 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 13

Table 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials 14

Table 7: Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development 15

Table 8: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 17

Table 9: Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 18

Table 10: DLP - Cam - Product Status 18

Table 11: DLP - Cam - Product Description 18

Table 12: ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

Table 13: Artemis 3 - Product Status 19

Table 14: Artemis 3 - Product Description 19

Table 15: ArcScan, Inc. - Ongoing Clinical Trials Overview 20

Table 16: Artemis 3 - Early Detection of Keratoconus 21

Table 17: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 22

Table 18: Diagnostic Tool - Retinal Disorders - Product Status 22

Table 19: Diagnostic Tool - Retinal Disorders - Product Description 22

Table 20: Bioinformative Institute of India Pipeline Products & Ongoing Clinical Trials Overview 23

Table 21: Ocular Surface Disease Diagnostic System - Product Status 23

Table 22: Ocular Surface Disease Diagnostic System - Product Description 23

Table 23: Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 24

Table 24: Advanced Retinal Imaging System - Product Status 24

Table 25: Advanced Retinal Imaging System - Product Description 24

Table 26: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 25

Table 27: Photoacoustic Imaging System - Product Status 25

Table 28: Photoacoustic Imaging System - Product Description 25

Table 29: CW Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 30: RetinalImager - Product Status 26

Table 31: RetinalImager - Product Description 26

Table 32: Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 27

Table 33: Eye Imaging Device - Product Status 27

Table 34: Eye Imaging Device - Product Description 27

Table 35: Eye Marker Systems Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

Table 36: RTD 1000 - Product Status 28

Table 37: RTD 1000 - Product Description 28

Table 38: Eye Tech Care SA Pipeline Products & Ongoing Clinical Trials Overview 29

Table 39: EyeOP1 - Product Status 29

Table 40: EyeOP1 - Product Description 29

Table 41: Eye Tech Care SA - Ongoing Clinical Trials Overview 30

Table 42: EyeOP1 - Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients 31

Table 43: Fovioptics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32

Table 44: Retinal Blood Analyzer - Product Status 32

Table 45: Retinal Blood Analyzer - Product Description 32

Table 46: Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 33

Table 47: Motorized C-arm System - Product Status 33

Table 48: Motorized C-arm System - Product Description 33

Table 49: George Washington University Pipeline Products & Ongoing Clinical Trials Overview 34

Table 50: iEye - Product Status 34

Table 51: iEye - Product Description 34

Table 52: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 35

Table 53: Portable Mydriatic Cameras - Product Status 35

Table 54: Portable Mydriatic Cameras - Product Description 35

Table 55: Retina Camera - Product Status 36

Table 56: Retina Camera - Product Description 36

Table 57: Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37

Table 58: Retinal Spectral Imaging System - Product Status 37

Table 59: Retinal Spectral Imaging System - Product Description 37

Table 60: OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 61: OcuMet Beacon - Product Status 38

Table 62: OcuMet Beacon - Product Description 38

Table 63: Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 39

Table 64: Ocutronics OC-100 Retinal Camera - Product Status 39

Table 65: Ocutronics OC-100 Retinal Camera - Product Description 39

Table 66: Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 40

Table 67: Interferometric Imaging System - Product Status 40

Table 68: Interferometric Imaging System - Product Description 40

Table 69: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 41

Table 70: 200TX Replacement Device - Product Status 41

Table 71: 200TX Replacement Device - Product Description 41

Table 72: CHARLOTTE - Product Status 42

Table 73: CHARLOTTE - Product Description 42

Table 74: INDIANAPOLIS - Product Status 42

Table 75: INDIANAPOLIS - Product Description 42

Table 76: Optos Plc - Ongoing Clinical Trials Overview 43

Table 77: 200TX Replacement Device - A Randomized Trial of Non-mydriatic Ultra-widefield Retinal Imaging to Screen for Diabetic Eye Disease: CLEAR SIGHT 44

Table 78: PCAsso Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 45

Table 79: PolyChromatic Angiography Device - Product Status 45

Table 80: PolyChromatic Angiography Device - Product Description 45

Table 81: Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 46

Table 82: VCSEL Based OCT System - Product Status 46

Table 83: VCSEL Based OCT System - Product Description 46

Table 84: Predictek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

Table 85: IRis - Product Status 47

Table 86: IRis - Product Description 47

Table 87: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 48

Table 88: Video Scheimpflug Camera - Product Status 48

Table 89: Video Scheimpflug Camera - Product Description 48

Table 90: RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Table 91: CAVCAM - Product Status 49

Table 92: CAVCAM - Product Description 49

Table 93: Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 50

Table 94: Optical Device - Product Status 50

Table 95: Optical Device - Product Description 50

Table 96: Tufts University Pipeline Products & Ongoing Clinical Trials Overview 51

Table 97: Digital Single Lens Reflex Adaptor - Product Status 51

Table 98: Digital Single Lens Reflex Adaptor - Product Description 51

Table 99: University College London Pipeline Products & Ongoing Clinical Trials Overview 52

Table 100: Ocular Imaging System - Product Status 52

Table 101: Ocular Imaging System - Product Description 52

Table 102: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 53

Table 103: Retinal Illumination System - Product Status 53

Table 104: Retinal Illumination System - Product Description 53

Table 105: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 54

Table 106: Corneal Hydration Sensing System - Product Status 54

Table 107: Corneal Hydration Sensing System - Product Description 54

Table 108: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 55

Table 109: Multi-Photon Optics Device - Product Status 55

Table 110: Multi-Photon Optics Device - Product Description 55

Table 111: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 56

Table 112: Adaptive Optics Ophthalmic Imager - Product Status 56

Table 113: Adaptive Optics Ophthalmic Imager - Product Description 56

Table 114: University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 57

Table 115: 3D Imaging Retinal Camera - Product Status 57

Table 116: 3D Imaging Retinal Camera - Product Description 57

Table 117: Vasoptic Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

Table 118: XyCAM RI - Product Status 58

Table 119: XyCAM RI - Product Description 58

Table 120: Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 59

Table 121: ViNM1 Retinal Camera - Product Status 59

Table 122: ViNM1 Retinal Camera - Product Description 59

Table 123: VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 60

Table 124: DR-RACS - Product Status 60

Table 125: DR-RACS - Product Description 60

Table 126: Functional Scanning Laser Ophthalmoscope - Product Status 61

Table 127: Functional Scanning Laser Ophthalmoscope - Product Description 61

Table 128: Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

Table 129: Aris HySpect - Product Status 62

Table 130: Aris HySpect - Product Description 62

Table 131: Aris Pixie - Product Status 63

Table 132: Aris Pixie - Product Description 63

Table 133: ArisWareEP-3D - Product Status 63

Table 134: ArisWareEP-3D - Product Description 63

Table 135: Glossary 99

1.2 List of Figures

Figure 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 9

Figure 2: Ophthalmic Imaging Equipment - Pipeline Products by Segment 10

Figure 3: Ophthalmic Imaging Equipment - Pipeline Products by Territory 11

Figure 4: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 12

Figure 5: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 13

Figure 6: Ophthalmic Imaging Equipment - Ongoing Clinical Trials 14

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2017

Share this report

Other tasks